Trade HOOKIPA Pharma Inc. - HOOK CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0348 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023485% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001262% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.0476 |
| Open | 1.0176 |
| 1-Year Change | 42.48% |
| Day's Range | 1.0176 - 1.0476 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 31, 2025 | 1.0476 | -0.1000 | -8.71% | 1.1476 | 1.1476 | 1.0376 |
| Mar 28, 2025 | 1.1676 | 0.0100 | 0.86% | 1.1576 | 1.2176 | 1.1476 |
| Mar 27, 2025 | 1.1576 | -0.0400 | -3.34% | 1.1976 | 1.2076 | 1.1576 |
| Mar 26, 2025 | 1.2076 | 0.0200 | 1.68% | 1.1876 | 1.2176 | 1.1876 |
| Mar 25, 2025 | 1.1876 | 0.0000 | 0.00% | 1.1876 | 1.1976 | 1.1876 |
| Mar 24, 2025 | 1.1976 | -0.0300 | -2.44% | 1.2276 | 1.2276 | 1.1876 |
| Mar 21, 2025 | 1.2076 | 0.0000 | 0.00% | 1.2076 | 1.2476 | 1.1876 |
| Mar 20, 2025 | 1.1976 | 0.0100 | 0.84% | 1.1876 | 1.2176 | 1.1576 |
| Mar 19, 2025 | 1.1876 | -0.0200 | -1.66% | 1.2076 | 1.2276 | 1.1576 |
| Mar 18, 2025 | 1.1976 | 0.0400 | 3.46% | 1.1576 | 1.2176 | 1.1576 |
| Mar 17, 2025 | 1.1676 | 0.0000 | 0.00% | 1.1676 | 1.2176 | 1.1576 |
| Mar 14, 2025 | 1.1576 | 0.0300 | 2.66% | 1.1276 | 1.1976 | 1.1176 |
| Mar 13, 2025 | 1.1576 | -0.0400 | -3.34% | 1.1976 | 1.3276 | 1.1376 |
| Mar 12, 2025 | 1.2376 | 0.1200 | 10.74% | 1.1176 | 1.2576 | 1.1176 |
| Mar 11, 2025 | 1.0976 | -0.0500 | -4.36% | 1.1476 | 1.1476 | 1.0876 |
| Mar 10, 2025 | 1.1876 | -0.0100 | -0.84% | 1.1976 | 1.2776 | 1.1876 |
| Mar 7, 2025 | 1.2676 | 0.0200 | 1.60% | 1.2476 | 1.2876 | 1.2476 |
| Mar 6, 2025 | 1.2876 | -0.0400 | -3.01% | 1.3276 | 1.3276 | 1.2176 |
| Mar 5, 2025 | 1.3276 | -0.0300 | -2.21% | 1.3576 | 1.4476 | 1.3276 |
| Mar 4, 2025 | 1.3776 | 0.0300 | 2.23% | 1.3476 | 1.3976 | 1.2976 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
HOOKIPA Pharma Inc. Company profile
About Hookipa Pharma Inc
HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The Company develops immunotherapeutics based on its arenavirus platform that are designed to target and amplify a T cell and immune response to disease. The Company's infectious and oncology product candidates HB-101, HB-201, HB-202 and HB-300. The infectious disease product candidate, HB-101, is in a randomized, double-blinded Phase II clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates, HB-201 and HB-202, are in development for the treatment of human papillomavirus-positive cancers. The Company is developing its self-antigen project in this area, HB-300, as a replicating technology-based product candidate in metastatic, hormone-resistant prostate cancer.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Hookipa Pharma Inc revenues increased 1% to $14.6M. Net loss increased 72% to $54.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development - Balancing val increase of 60% to $58M (expense), Other income and expenses, net decrease from $1.6M (income) to $1.3M (expense).
| Industry: | Pharmaceuticals (NEC) |
The Empire State Building
350 Fifth Avenue, Room/Suite 7240
NEW YORK
NEW YORK 10118
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com